dr perlmutter parkinsons treatment glutathione Small Molecules, α-Synuclein Pathology, and the Search for Effective Treatments in Parkinson's Disease Targeting Mitochondria as a Therapeutic
Targeting Mitochondria as a Therapeutic Approach for Parkinson's Disease Cellular and Molecular Neurobiology Springer Nature Link Having a larger waistline, high blood pressure and other risk factors that make up metabolic syndrome is associated with an increased risk of Parkinson's disease, according to a study published on August Initial management of Parkinson's disease The BMJ Perlmutter to conclude deanship in 2026 The Source WashU Frontiers From pathogenesis to treatment: the emerging role of ferroptosis in Parkinson's disease
Pay in 4 interest-free payments of $5.02 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



